Exp Physiol. 2018 Jul 14. doi: 10.1113/EP086964. [Epub ahead of print]
Kourtzidis IA1, Dolopikou CF1, Tsiftsis AN1,2, Margaritelis NV1,2, Theodorou AA3, Zervos IA4, Tsantarliotou MP4, Veskoukis AS1,5, Vrabas IS1, Paschalis V3,6, Kyparos A1, Nikolaidis MG1.
Nicotinamide riboside ... can increase NAD(P) levels. NAD(P) play key roles in energy metabolism and their main function is the transfer of electrons in various cellular reactions. Research in aged or diseased mice reported that nicotinamide riboside increases NAD(H) levels, reduces morbidity and improves health and muscle function.
We have recently shown that in healthy young rats, chronic administration of nicotinamide riboside decreased exercise performance by 35% (p = 0.071). [MR: we have discussed that earlier study (PMID: 27489522) before: see here, here, and later in that thread].
As a follow-up to this finding, we analyzed samples from these animals, trying to reveal the potential mechanisms driving this adverse effect, focusing on redox homeostasis and bioenergetics. ... Nicotinamide riboside supplementation increased the levels of NADPH in liver (P = .050), increased the levels of F2 -isoprostanes [a marker of lipid peroxidation] in plasma (P = .047), decreased the activity of glutathione peroxidase (P = .017), glutathione reductase (P < .001) and catalase (P = .024) [antioxidant enzymes] in erythrocytes, increased the levels of glycogen in liver (P < .001) and decreased the levels of glucose (P = .016) and maximal lactate accumulation in plasma (P = .084). [MR: These last three might be taken to be good things in a person while inactive, but in the context of exercise to exhaustion could indicate a failure to release needed fuel from the glycogen stores].
These findings support the prevailing idea that exogenously administered redox agents in heathy populations may lead to adverse and not necessarily to beneficial or neutral effects.
PMID: 30007015
DOI: 10.1113/EP086964
As we've discussed before, it certainly seems plausible that these effects might be seen in very young animals (including human animals) while still being benficial "in aged or diseased" mice and people. Such beneficial effects have not been exactly shining through in human trials, however.